|
WINNIPEG, MANITOBA--(Marketwired - Nov. 23, 2015) - Miraculins Inc. (TSX VENTURE:MOM) (the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk assessment technologies for unmet clinical needs, today announces that it has entered into amending agreements to extend the maturity dates of its CDN$1,000,000 non-convertible secured loan, from a lender (the "2011 Lender") that was originally announced on October 13, 2011 and previously extended twice, on December 23, 2013 and May 16, 2014, and its CDN$611,334 non-convertible secured loan, from a lender (the "2013 Lender") that was originally announced on December 23, 2013 and previously extended on May 16, 2014 (collectively the "Loans"). |
